Resolution of severe macular oedema in adult Coat's syndrome with high-dose intravitreal triamcinolone acetonide.
OBJECTIVE
To report the clinical outcome of a patient who received high-dose intravitreal triamcinolone acetonide as treatment for severe macular oedema secondary to adult Coat's syndrome.


METHODS
Case report.


RESULTS
A 74-year-old Indian man complaining of chronic gradual blurring of vision in the left eye was found to have adult Coat's syndrome with severe macular oedema. He received 25 mg of intravitreal triamcinolone acetonide following unsuccessful resolution with grid laser. Optical coherence tomography (OCT) demonstrated up to 75% decrease in macular oedema that was evident even after 9 months follow-up. However, there was no significant improvement in visual acuity.


CONCLUSIONS
Intravitreal triamcinolone is a reasonable option in reducing severe macular oedema in cases of adult Coat's syndrome.
Jarin
R R
RR
The Eye Institute, Tan Tock Seng Hospital, Singapore, Republic of Singapore.
Teoh
S C B
SC
Lim
T H
TH
D000368:Aged; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D008269:Macular Edema / Q000188:drug therapy*; D008297:Male; D012171:Retinal Vessels; D013577:Syndrome; D013684:Telangiectasis / Q000628:therapy; D041623:Tomography, Optical Coherence; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*
D005938:Glucocorticoids; D014222:Triamcinolone Acetonide